Private healthcare makes industries less innovative. It's time for change
Commenters debate how health system design — especially the U.S. model of employer‑tied, largely private insurance — constrains labor mobility, suppresses wages, and can dampen innovation by making people afraid to leave stable jobs. Many contrast this with various forms of universal or single‑payer care in Europe and Canada, noting both their strengths (protection from bankruptcy, better average outcomes) and weaknesses (wait times, underfunding, limited capacity). Across models, participants highlight misaligned incentives, artificial scarcity of medical professionals, and tax policy as core drivers of high costs and poor experiences, while differing on whether the solution is more market competition, stronger public options, or fully universal coverage.
Private vs. “Free” Healthcare Models
- Many distinguish “private healthcare” from “lack of universal coverage”; the core problem is seen as absence of universal access, not private providers per se.
- Several note that mixed systems (single payer + private providers) are common; Canada and the UK already have private actors within publicly funded systems.
- Others argue the real issue in the article is not private care but employer-tied insurance and tax policy.
Employer-Provided Insurance and Labor Mobility
- Widely agreed that tying insurance to jobs reduces job mobility, suppresses wages, and discourages entrepreneurship and startups.
- Some want tax advantages shifted from employers to individuals (e.g., employer-funded HSAs or cash instead of plans).
- Others doubt transition mechanics (e.g., risk of people dropping coverage, need for mandates or credits) and note employers still like insurance as a retention tool.
Markets, Incentives, and Regulation
- One camp argues more genuine market competition (transparent prices, skin in the game, decoupling from employment) would lower costs and spur innovation.
- Another camp says healthcare is structurally ill-suited to free-market dynamics: adverse selection, preexisting conditions, low price elasticity, and complex risk pools.
- Disagreement over how “inaccessible” individual insurance was pre-ACA, and how much ACA “marketized” vs socialized the system.
International Comparisons (US, Canada, Europe)
- Europeans and some Americans emphasize that most rich countries combine universal coverage with private insurance and providers, heavily regulated and often “free at point of service.”
- Canadian commenters highlight severe wait times and underfunding, but still prefer their model to the US’s, seeing triage queues as better than price-based exclusion.
- Some argue US uniqueness lies in extreme inefficiency, fragmented payers, opaque pricing, and high provider incomes.
Costs, Innovation, and Access
- One view: profit motive and high US prices fund global innovation; others counter that much innovation also comes from academia and non-US firms.
- Several see US administrative/billing overhead and insurer interference as massive cost drivers, with insurers effectively acting as de facto care gatekeepers.
Capacity and Workforce Constraints
- Many note that doctor and nurse supply is artificially constrained (e.g., residency caps, licensing, long training pipelines), making any model hard to scale.
- Proposed fixes range from expanded use of nurse practitioners to radical deregulation of medical practice; safety and quality implications are contested.